The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
The Department of Psychology at the University of Kansas aims to further the understanding of the mind, brain, and human behavior through teaching, research, and service. It prepares undergraduate and graduate students to become leaders in psychological sciences and other professions.
Investigates the relationship between psychology and behavior, covering cognition, emotion, and behavior.
MedSci.cn provides medical calculation formulas and tools to help doctors and researchers conduct clinical and scientific research.